All practice questions

8270 questions

Question 2441Question →

A 24-year-old man comes to the clinic due to a sore on his penis that he noticed 5 days ago. He reports no pain, itching, or penile discharge. He is sexually active with a new male partner and does not use condoms consistently. Vital signs are within normal limits. Physical examination reveals a single, 1.5-cm, sharply circumscribed, indurated, and painless ulcer on the penile shaft. Bilateral, non-tender inguinal lymphadenopathy is present. Which of the following is the most appropriate pharmacotherapy for this patient?

Show answer & explanation

Answer: Intramuscular benzathine penicillin G

Answer

Intramuscular benzathine penicillin G
The patient's painless, indurated genital ulcer with non-tender inguinal lymphadenopathy is the classic presentation of a primary syphilitic chancre, caused by the spirochete Treponema pallidum. The most appropriate first-line treatment for primary, secondary, and early latent syphilis is a single dose of intramuscular benzathine penicillin G.

Step-by-Step Solution

1
Analyze the clinical presentation of the genital ulcer.
The patient has a single, indurated, sharply circumscribed, and painless ulcer accompanied by non-tender inguinal lymphadenopathy.
Identifying the specific characteristics of genital ulcers (painful vs. painless, single vs. multiple, purulent vs. clean) is essential for diagnosing the underlying sexually transmitted infection.
2
Formulate the most likely diagnosis.
The classic presentation of a painless chancre indicates primary syphilis caused by Treponema pallidum.
Other common causes of genital ulcers, such as herpes simplex virus and Haemophilus ducreyi, typically present with painful lesions.
3
Select the appropriate pharmacotherapy based on the diagnosis.
Intramuscular benzathine penicillin G is selected.
A single dose of long-acting intramuscular benzathine penicillin G is the standard of care and highly effective first-line therapy for primary, secondary, and early latent syphilis.

Key Concept

The hallmark of primary syphilis is a painless, indurated genital chancre, and the standard first-line treatment is a single dose of intramuscular benzathine penicillin G.
Estimated Time:45s
Question 2442Question →

A 68-year-old female presents to the outpatient clinic reporting progressive fatigue and shortness of breath with minimal exertion over the past three months. Her past medical history includes chronic obstructive pulmonary disease and primary hypothyroidism. Her current medications include inhaled tiotropium and oral levothyroxine. Vital signs are within normal limits. Pulse oximetry is 96%96\% on room air. Physical examination reveals marked conjunctival pallor. Lung fields are clear to auscultation bilaterally, and there is no jugular venous distention or peripheral edema.

Laboratory studies reveal the following:
Hemoglobin: 7.1 g/dL7.1\text{ g/dL}
Mean corpuscular volume: 115 fL115\text{ fL}
White blood cell count: 4,500/mm34,500/\text{mm}^3
Platelet count: 160,000/mm3160,000/\text{mm}^3
Thyroid-stimulating hormone: 2.4 μU/mL2.4\text{ }\mu\text{U/mL} (normal: 0.4−4.0 μU/mL0.4-4.0\text{ }\mu\text{U/mL})

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Measure serum vitamin B12 and folate levels

Answer

Measure serum vitamin B12 and folate levels
The correct answer accurately identifies the next step for a patient presenting with an elevated mean corpuscular volume (MCV > 100 fL). The most common causes of macrocytic anemia are vitamin B12 and folate deficiencies, and these levels should be obtained as the first step in the diagnostic workup.

Step-by-Step Solution

1
Identify the primary clinical abnormality based on laboratory findings.
The patient has symptomatic severe anemia (hemoglobin 7.1 g/dL7.1\text{ g/dL}) with macrocytosis (mean corpuscular volume 115 fL115\text{ fL}).
Recognizing the predominant laboratory abnormality directs the diagnostic algorithm.
2
Evaluate the clinical presentation against the patient's comorbidities.
The normal thyroid-stimulating hormone rules out uncontrolled hypothyroidism. The clear lungs and normal oxygen saturation rule out an acute cardiopulmonary exacerbation.
This ensures that symptoms of fatigue and dyspnea are correctly attributed to the anemia rather than chronic diseases.
3
Select the appropriate initial test for the identified anemia.
Vitamin B12 and folate levels are indicated.
These are the most common causes of macrocytic anemia and must be evaluated first to guide definitive therapy.

Key Concept

The initial diagnostic step for macrocytic anemia (elevated mean corpuscular volume) includes checking serum vitamin B12 and folate levels.
Question 2443Question →

A 65-year-old man with a history of metastatic prostate cancer presents to the emergency department with a 2-day history of progressive lower extremity weakness, sensory loss below the umbilicus, and new-onset urinary retention. Physical examination reveals paraparesis, hyperreflexia in both lower extremities, and decreased rectal sphincter tone. Arrange the following steps in the most appropriate chronological sequence for the evaluation and management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of management is to first administer intravenous dexamethasone, followed by an MRI of the entire spine, then obtain surgical and radiation oncology consultations, and finally proceed with definitive decompression or radiation therapy.
The patient's clinical presentation is highly suspicious for malignant epidural spinal cord compression (ESCC), a true oncologic emergency. The primary goal of initial management is to prevent irreversible neurologic loss. Therefore, the immediate first step is the administration of high-dose intravenous corticosteroids (e.g., dexamethasone) to decrease vasogenic edema around the spinal cord. Once steroids are given, the diagnosis must be confirmed and localized with an urgent MRI of the entire spine. Following MRI confirmation, urgent consultations with neurosurgery and radiation oncology are needed to determine the optimal definitive intervention, which is then executed as the final step in the sequence.

Step-by-Step Solution

1
Recognize the clinical presentation of epidural spinal cord compression (ESCC).
The patient's history of prostate cancer, rapidly progressive paraparesis, sensory level, and bowel/bladder dysfunction strongly indicate ESCC.
Identifying this presentation as an acute oncologic emergency dictates the urgency of subsequent management steps to prevent permanent paralysis.
2
Prioritize immediate neurologic preservation over diagnostic confirmation.
High-dose intravenous dexamethasone is administered as the very first step.
Corticosteroids rapidly reduce vasogenic edema surrounding the spinal cord, relieving pressure and preventing irreversible neurologic ischemia.
3
Obtain diagnostic confirmation and anatomical localization.
Urgent MRI of the entire spine is performed.
MRI is required to visualize the exact location and extent of the tumor, which is essential for planning subsequent interventions.
4
Formulate and execute a definitive multidisciplinary treatment plan.
Specialists are consulted, followed by surgical decompression or primary radiation therapy.
Definitive management depends on multiple variables (e.g., spinal instability, tumor radiosensitivity, patient prognosis), requiring specialized surgical and oncologic expertise.

Key Concept

In patients with suspected malignant epidural spinal cord compression presenting with neurologic deficits, immediate administration of high-dose corticosteroids is the absolute first step in management, which must occur prior to confirmatory imaging with an MRI.
Question 2444Question →

Match each pediatric patient presenting for a clinical visit with the most appropriate next step in their preventive care or immunization management.

Click a left item, then click its matching right item

Items

A 12-month-old boy with severe congenital T-cell lymphopenia (e.g., severe combined immunodeficiency) presenting for a well-child visit.
A 12-month-old girl whose mother received high-dose infliximab therapy throughout the third trimester of pregnancy, presenting for routine immunizations.
A 15-month-old girl presenting for routine immunizations whose household sibling recently underwent a bone marrow transplant and is severely immunocompromised.
A 4-month-old boy who was treated with intravenous immune globulin (IVIG) for Kawasaki disease 4 weeks ago, presenting for routine immunizations.
A 7-year-old boy with no prior immunizations presenting with a deep, dirty puncture wound from a rusted metal fence.

Matches

Show answer & explanation

Answer

The correct matches align specific high-risk pediatric scenarios with their respective modified immunization or post-exposure prophylaxis protocols based on altered immunocompetence, household exposures, and age constraints.
Each match correctly applies ACIP and Bright Futures guidelines for exceptional pediatric populations. The rules for live vaccines depend heavily on the mechanism of immunosuppression (cellular vs. passive antibody), the route of vaccine administration (parenteral vs. mucosal), and the exact timeline of exposure.

Step-by-Step Solution

1
Evaluate the 12-month-old with severe T-cell lymphopenia.
Match with withholding all live-attenuated vaccines.
Patients with severe cellular immunodeficiency cannot mount an adequate response to, and cannot safely clear, the attenuated viruses in live vaccines. Administration can cause fatal disseminated vaccine-strain infection.
2
Evaluate the 12-month-old with in utero infliximab exposure.
Match with administering MMR and varicella vaccines without delay.
IgG monoclonal antibodies cross the placenta. Infants are considered immunosuppressed for the first 6 months of life, contraindicating early live vaccines like rotavirus. At 12 months, the infant's immune system is normal, and MMR/varicella are safe.
3
Evaluate the 15-month-old sibling of a bone marrow transplant recipient.
Match with administering MMR/varicella but avoiding LAIV.
To protect immunocompromised family members, healthy contacts should be fully immunized, including with MMR and varicella. The only exception is LAIV (nasal flu spray), which is contraindicated because the attenuated virus can be shed and transmitted to the transplant recipient.
4
Evaluate the 4-month-old who received IVIG 4 weeks ago.
Match with administering the scheduled oral rotavirus vaccine.
IVIG provides passive serum IgG that interferes with injected live vaccines (MMR, varicella), necessitating a delay. It does not interfere with mucosal IgA responses in the gastrointestinal tract, so the live oral rotavirus vaccine is given on its strict age-based schedule.
5
Evaluate the completely unimmunized 7-year-old with a dirty wound.
Match with administering Tdap and TIG.
Unknown or <3 doses of tetanus toxoid plus a dirty wound requires both active (vaccine) and passive (TIG) prophylaxis. At age 7 years, the correct formulation is Tdap, as DTaP is contraindicated at age 7 and older.

Key Concept

Complex immunization management requires understanding the distinctions between cellular vs. humoral immunodeficiency, parenteral vs. mucosal live vaccines, and strict age cutoffs for specific vaccine formulations.
Question 2445Question →

Macrosomic neonates are at increased risk for birth trauma, particularly during difficult or operative vaginal deliveries. Match each characteristic clinical presentation observed during the newborn physical examination with its most likely traumatic etiology.

Click a left item, then click its matching right item

Items

Adducted and internally rotated right arm with forearm pronation; absent Moro reflex but intact grasp on the affected side.
Claw-like posturing of the left hand with an absent grasp reflex, accompanied by ipsilateral ptosis and miosis.
Crepitus and palpable bony step-off over the anterior shoulder; decreased spontaneous arm movement but normal reflexes.
Respiratory distress with asymmetric chest wall expansion and paradoxical abdominal movement during inspiration.

Matches

Show answer & explanation

Answer

The presentations match as follows: 'waiter's tip' posture matches upper trunk injury (Erb palsy), claw hand with Horner syndrome matches lower trunk injury (Klumpke palsy), shoulder crepitus matches clavicular fracture, and asymmetric breathing matches phrenic nerve injury.
Each clinical presentation is a classic manifestation of a specific birth trauma. Accurate diagnosis requires localizing the neurological deficit (proximal vs. distal muscles) and identifying associated structural findings (crepitus, sympathetic deficit, or diaphragmatic paralysis).

Step-by-Step Solution

1
Analyze the pattern of motor deficits in the newborn's upper extremity.
Proximal weakness with an intact grasp indicates C5-C6 involvement; distal weakness with an absent grasp indicates C8-T1 involvement.
Different roots of the brachial plexus innervate specific muscle groups, allowing for precise clinical localization.
2
Assess for associated non-motor or extra-extremity physical signs.
Ipsilateral ptosis/miosis points to T1 sympathetic chain involvement; respiratory distress points to cervical roots C3-C5; crepitus points to a mechanical bone injury.
Recognizing associated findings helps differentiate isolated brachial plexus injuries from those involving adjacent structures or primary bone trauma.

Key Concept

Differentiating neonatal birth traumas based on characteristic physical examination findings and neurological localization.
Question 2446Question →

Review the following physical examination findings of skin lesions in newborn infants. Associate each dermatologic presentation with its corresponding diagnosis.

Click a left item, then click its matching right item

Items

A 48-hour-old infant develops multiple erythematous macules on the trunk and extremities, some containing central yellow pustules; a smear of the pustules reveals numerous eosinophils.
A neonate is noted at birth to have scattered superficial pustules that easily rupture, leaving behind hyperpigmented macules with a collarette of scale; a smear reveals neutrophils.
A 24-hour-old infant presents with numerous tiny, 1-to-2 millimeter pearly white papules clustered over the nose, cheeks, and chin without surrounding erythema.
A 21-day-old infant develops inflammatory papules and pustules confined to the face and scalp, notably lacking comedones.

Matches

Show answer & explanation

Answer

The presentations match as follows: The infant with eosinophil-filled pustules has Erythema toxicum neonatorum. The newborn with neutrophil-filled pustules and hyperpigmented macules has Transient neonatal pustular melanosis. The infant with pearly white facial papules has Milia. The 21-day-old with facial papules lacking comedones has Neonatal cephalic pustulosis.
The correct pairings rely on identifying the classic distinguishing features of benign neonatal rashes. Erythema toxicum neonatorum typically appears a few days after birth and features eosinophil-filled pustules on an erythematous base. In contrast, Transient neonatal pustular melanosis is present at birth, lacks an erythematous base, contains neutrophils, and leaves hyperpigmented macules. Milia are simple keratin-filled cysts appearing as pearly white papules. Neonatal cephalic pustulosis presents later (around 3 weeks) with facial papules that specifically lack the comedones seen in true acne.

Step-by-Step Solution

1
Analyze the first presentation involving an erythematous rash with eosinophil-filled pustules appearing at 48 hours of life.
This pattern points to a common, benign newborn rash.
The presence of eosinophils and an erythematous base are the classic hallmarks of Erythema toxicum neonatorum.
2
Evaluate the second presentation involving neutrophil-filled pustules present at birth that leave hyperpigmented macules.
This indicates a specific transient eruption seen in neonates.
The lack of surrounding erythema, presence at birth, and neutrophil content define Transient neonatal pustular melanosis.
3
Assess the third presentation involving 1-to-2 millimeter pearly white papules on the face.
This indicates retention of keratin and sebaceous material.
These pinpoint white papules are characteristic of Milia.
4
Review the fourth presentation involving inflammatory facial papules at 3 weeks of age without comedones.
This indicates a condition similar to acne but lacking true comedones.
The timing and absence of comedones are the key distinguishing features of Neonatal cephalic pustulosis.

Key Concept

Differentiating benign neonatal skin eruptions based on timing of onset, physical appearance, and cellular contents of pustules.
Question 2447Question →

A 9-month-old boy is brought to the clinic by his parents for a pre-travel consultation. The family will be traveling next week to a country experiencing an ongoing measles outbreak and plans to stay for two months. The patient was born at term, has no significant medical history, and is developing normally. He has received all routine childhood immunizations recommended for his age in the United States. His vital signs are within normal limits, and physical examination is unremarkable. Which of the following is the most appropriate recommendation regarding measles immunization for this patient?

Show answer & explanation

Answer: Administer one dose of the measles, mumps, and rubella (MMR) vaccine today, and administer the next routine dose at age 12 to 15 months.

Answer

The most appropriate action is to administer one dose of the MMR vaccine today, followed by the routine dose at 12 to 15 months.
The correct action is to administer the MMR vaccine today and continue with the routine series at 12 to 15 months. The standard childhood immunization schedule recommends the first dose of the live-attenuated measles, mumps, and rubella (MMR) vaccine at 12 to 15 months of age. Administration is delayed until this age because circulating transplacental maternal antibodies can interfere with the infant's ability to mount a robust and lasting immune response to the vaccine virus. However, infants between 6 and 11 months of age have waning maternal antibodies and are highly susceptible to measles infection. Therefore, for infants in this age group who are traveling internationally to areas with endemic measles or active outbreaks, the CDC recommends administering an early dose of the MMR vaccine to provide temporary protection. Because of the potential for blunted immunogenicity from residual maternal antibodies, this early dose is considered invalid for the routine series. The child must still receive the standard two doses (at 12-15 months and 4-6 years) to ensure lifelong immunity.

Step-by-Step Solution

1
Identify the patient's age and travel risk.
The patient is a 9-month-old infant traveling to a measles-endemic area.
Risk assessment determines whether standard immunization schedules need to be adjusted.
2
Determine the indication for measles vaccination in this age group.
Infants 6-11 months of age traveling internationally should receive an early dose of the MMR vaccine.
Maternal antibodies wane by this age, leaving the infant vulnerable in high-prevalence areas.
3
Evaluate how this early dose affects the routine schedule.
The early dose does not count toward the routine 2-dose series.
Maternal antibodies can blunt the immune response to the vaccine before 12 months of age, so the routine series must still be completed starting at 12-15 months.

Key Concept

Infants aged 6 to 11 months who are traveling internationally should receive one dose of the MMR vaccine prior to departure. This dose does not count toward the routine 2-dose series, which must still be administered starting at 12 to 15 months of age.
Question 2448Question →

An 88-day-old newborn is evaluated in the pediatric clinic for a routine well-child visit. The mother is concerned about a skin eruption that appeared on the infant's face three days ago, which seemed to worsen after they sat in a sunlit room. The infant was born at 3939 weeks gestation via an uncomplicated vaginal delivery and is exclusively breastfeeding well. The mother is a 2828-year-old primigravida who has a history of episodic joint stiffness and cold-induced finger discoloration, for which she has not sought medical care. The infant's vital signs include a temperature of 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure of 65/40 mmHg65/40 \text{ mmHg}, respiratory rate of 36/min36/\text{min}, and a heart rate of 72/min72/\text{min}. Physical examination of the infant reveals erythematous, annular plaques with slightly raised and scaly borders concentrated around the periorbital regions and scalp. The anterior fontanelle is flat and soft, and the lungs are clear to auscultation. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Perform an electrocardiogram

Answer

Perform an electrocardiogram
The correct answer is to perform an electrocardiogram. This infant presents with an erythematous, annular, and photosensitive rash predominantly affecting the periorbital regions (often described as 'raccoon eyes') and scalp. Combined with a maternal history suggestive of an undiagnosed connective tissue disease (joint stiffness, Raynaud phenomenon), this presentation is highly characteristic of neonatal lupus erythematosus (NLE). NLE is a passively transferred autoimmune disease caused by maternal anti-Ro/SSA and anti-La/SSB antibodies crossing the placenta. While the cutaneous findings are transient and resolve as maternal antibodies clear, the most serious complication is congenital heart block, which is often irreversible. This infant has profound resting bradycardia (heart rate 72/min72/\text{min}; normal is 110110-160/min160/\text{min}). An electrocardiogram is the essential next step to evaluate the cardiac rhythm and confirm the degree of atrioventricular block. Third-degree (complete) heart block may require immediate pacemaker placement.

Step-by-Step Solution

1
Evaluate the infant's vital signs against normal neonatal parameters.
The infant has profound bradycardia. A normal neonatal heart rate is 110110-160/min160/\text{min}, making a resting heart rate of 72/min72/\text{min} highly abnormal and concerning.
Identifying abnormal vital signs is the first crucial step in recognizing a potentially life-threatening condition.
2
Synthesize the infant's physical examination findings with the maternal history.
The infant's photosensitive, annular periorbital rash ('raccoon eyes'), combined with the mother's history of joint pain and Raynaud phenomenon, strongly suggests Neonatal Lupus Erythematosus (NLE).
NLE is an acquired autoimmune condition caused by the transplacental passage of maternal anti-Ro/SSA and anti-La/SSB antibodies.
3
Identify the most critical complication associated with the suspected diagnosis.
The most serious and potentially irreversible complication of NLE is congenital atrioventricular (AV) heart block, which accounts for the patient's severe bradycardia.
Congenital heart block has high morbidity and mortality, requiring immediate diagnostic confirmation.
4
Determine the most appropriate diagnostic test to assess the complication.
An electrocardiogram (ECG) must be performed immediately.
An ECG is required to determine the presence and degree of heart block, guiding the need for potential pacemaker placement.

Key Concept

Neonatal Lupus Erythematosus (NLE) and Congenital Heart Block
Question 2449Question →

A pediatric clinic is auditing patient records to ensure adherence to specialized immunization guidelines for high-risk patients. Match each pediatric patient scenario with the most appropriate vaccine indication, absolute contraindication, or management step.

Click a left item, then click its matching right item

Items

A 4-year-old child with a newly placed cochlear implant who has received all routine childhood vaccinations
A 10-year-old child with sickle cell anemia presenting for a well-child visit, previously up-to-date on all condition-specific vaccinations
A 12-month-old infant with DiGeorge syndrome and a documented severe T-lymphocyte deficiency
A 7-year-old child who received high-dose intravenous immunoglobulin (IVIG) for Kawasaki disease exactly 3 months ago
A 15-year-old adolescent presenting for catch-up immunizations with a documented history of anaphylaxis to baker's yeast

Matches

Show answer & explanation

Answer

The correct pairings match each specialized clinical scenario to its corresponding vaccine management guideline based on structural defects (PPSV23 for cochlear implants), functional asplenia (MenB starting at age 10), severe cellular immunodeficiency (absolute MMR contraindication), passive immunity interference (11-month live vaccine deferral post-IVIG), and specific allergies (HepB/HPV contraindication for yeast allergy).
Each patient requires a specialized modification to the routine immunization schedule. Cochlear implants necessitate PPSV23 due to an increased risk of pneumococcal meningitis from potential CSF leaks. Functional asplenia requires MenB starting at age 10. Severe T-cell defects are absolute contraindications to live vaccines (MMR). High-dose IVIG for Kawasaki disease requires an 11-month temporary deferral of live vaccines (yielding 8 months remaining if 3 months have passed). Yeast anaphylaxis strictly contraindicates the HepB and HPV vaccines.

Step-by-Step Solution

1
Identify the underlying high-risk condition or status in each pediatric patient.
Recognize the presence of a cochlear implant, functional asplenia (sickle cell), severe T-cell deficiency, recent high-dose IVIG, and baker's yeast anaphylaxis.
Vaccine indications and contraindications depend heavily on these specific historical and clinical details rather than chronological age alone.
2
Determine appropriate pneumococcal and meningococcal vaccine indications for structural and functional defects.
The 4-year-old with a cochlear implant needs PPSV23. The 10-year-old with sickle cell anemia is newly eligible to start the MenB series.
Cochlear implants selectively increase pneumococcal meningitis risk (PPSV23 indicated >2 yrs). Asplenia increases broad encapsulated risk, and MenB is specifically approved and initiated at age 10.
3
Differentiate between temporary deferrals and absolute contraindications for live-attenuated vaccines.
The infant with severe T-cell deficiency has an absolute contraindication to MMR. The child who received IVIG 3 months ago requires an 11-month total deferral (8 additional months remaining).
Cellular immunodeficiency carries a fatal risk of vaccine-strain infection (absolute). Passive antibodies from IVIG merely blunt the immune response without causing harm (temporary).
4
Identify vaccine components related to specific severe allergies.
The adolescent with baker's yeast anaphylaxis cannot receive Hepatitis B or HPV vaccines.
Both of these vaccines are propagated in Saccharomyces cerevisiae and contain residual yeast proteins.

Key Concept

Vaccine modifications in special pediatric populations (immunocompromised, anatomic/functional defects, and specific allergies)
Estimated Time:2m 0s
Question 2450Question →

A 39-week gestation male neonate is born via spontaneous vaginal delivery to a 28-year-old primigravida. The pregnancy was uncomplicated. At birth, the neonate is limp, apneic, and cyanotic. Place the following steps of neonatal resuscitation in the correct chronological order of execution according to standard neonatal resuscitation guidelines, assuming the neonate's clinical status does not improve and the heart rate remains consistently below 60/min despite each successive intervention.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: initial steps (warmth, drying, stimulation) -> initiate PPV -> perform ventilation corrective steps -> commence chest compressions -> administer intravenous epinephrine.
The Neonatal Resuscitation Program (NRP) algorithm dictates a specific sequence to ensure that the primary cause of neonatal compromise—respiratory failure and hypoxia—is addressed first. The sequence begins with initial steps (warmth, drying, stimulation, clearing airway). If the infant remains apneic or the heart rate is < 100/min, PPV is initiated. If PPV fails to increase the heart rate and move the chest, ventilation corrective steps are performed. Only after establishing effective ventilation (chest movement) for 30 seconds, if the heart rate remains < 60/min, are chest compressions started alongside 100% oxygen. Finally, if the heart rate remains < 60/min after 60 seconds of coordinated compressions and effective PPV, intravenous epinephrine is administered.

Step-by-Step Solution

1
Identify the immediate requirements for a non-vigorous, apneic neonate at birth.
The first step is always to provide warmth, dry the infant, position the airway, and provide tactile stimulation.
Basic supportive care and stimulation can often restore spontaneous breathing and circulation without further invasive measures.
2
Determine the next step for persistent apnea or bradycardia (heart rate < 100/min) after initial steps.
Initiate positive-pressure ventilation (PPV) and attach monitoring equipment (pulse oximeter and ECG).
Neonatal bradycardia is typically secondary to hypoxia; establishing ventilation is the most critical intervention in neonatal resuscitation.
3
Determine the necessary action when PPV does not improve the heart rate and the chest is not moving.
Perform ventilation corrective steps (often memorized as MR. SOPA: Mask adjustment, Reposition airway, Suction mouth/nose, Open mouth, Pressure increase, Alternative airway).
Effective ventilation must be assured before escalating to compressions. Chest movement is the primary clinical indicator of effective PPV.
4
Identify the clinical threshold for initiating chest compressions.
Commence coordinated chest compressions and increase fractional inspired oxygen to 100%.
Compressions are indicated only if the heart rate remains < 60/min after at least 30 seconds of effective PPV that visibly moves the chest.
5
Determine when to administer resuscitation medications.
Administer intravenous epinephrine.
Epinephrine is indicated if the heart rate remains < 60/min despite 60 seconds of coordinated chest compressions and effective PPV.

Key Concept

Neonatal resuscitation follows a strict stepwise progression focused primarily on establishing effective ventilation, as hypoxia is the most common cause of neonatal bradycardia.
Question 2451Question →

A 5858-year-old man is evaluated in the intensive care unit for worsening respiratory status. Eight days ago, he was intubated following a severe motor vehicle collision. Over the past 2424 hours, his oxygen requirements have increased, and he has developed a fever of 38.9∘C38.9^\circ\text{C} (102.0∘F102.0^\circ\text{F}). Copious thick, purulent secretions are noted in the endotracheal tube. Physical examination reveals coarse rhonchi over the right lung field. Laboratory studies show a leukocyte count of 16,500/mm316,500/\text{mm}^3 with 85%85\% neutrophils. A chest radiograph demonstrates a new dense consolidation in the right lower lobe. The patient was empirically started on intravenous vancomycin, piperacillin-tazobactam, and amikacin.

Today, the quantitative endotracheal aspirate culture returns positive for >105 CFU/mL>10^5\text{ CFU/mL} of *Pseudomonas aeruginosa*. The isolate is susceptible to piperacillin-tazobactam, cefepime, meropenem, and amikacin. Blood cultures show no growth. His serum creatinine has increased from 1.0 mg/dL1.0\text{ mg/dL} on admission to 2.3 mg/dL2.3\text{ mg/dL} today.

Which of the following is the most appropriate next step in pharmacotherapy?

Show answer & explanation

Answer: Discontinue vancomycin and amikacin; continue piperacillin-tazobactam

Answer

The most appropriate next step is to discontinue vancomycin and amikacin, and continue piperacillin-tazobactam monotherapy.
The correct answer discontinues both vancomycin and amikacin while continuing piperacillin-tazobactam. This patient developed ventilator-associated pneumonia (VAP), and empiric therapy appropriately included coverage for MRSA (vancomycin) and dual coverage for Pseudomonas (piperacillin-tazobactam and amikacin). Once culture and susceptibility results are available, therapy must be de-escalated to targeted treatment. Since no MRSA was isolated, vancomycin should be stopped. For definitive therapy of P. aeruginosa VAP, once in vitro susceptibility to a beta-lactam (like piperacillin-tazobactam) is confirmed, double coverage with an aminoglycoside is no longer recommended because it does not improve outcomes and increases the risk of toxicity. Given this patient's rising creatinine (acute kidney injury), discontinuing the nephrotoxic aminoglycoside is especially critical. Therefore, monotherapy with piperacillin-tazobactam is the most appropriate definitive step.

Step-by-Step Solution

1
Interpret the clinical presentation and culture results.
The patient has ventilator-associated pneumonia (VAP) caused by Pseudomonas aeruginosa, which is susceptible to piperacillin-tazobactam.
Establishing the definitive microbiological diagnosis is required to tailor antimicrobial therapy.
2
Evaluate the indication for continuing methicillin-resistant Staphylococcus aureus (MRSA) coverage.
Discontinue vancomycin.
The respiratory culture did not grow MRSA, making ongoing empiric coverage unnecessary and contrary to antibiotic stewardship principles.
3
Determine the optimal antipseudomonal regimen based on susceptibilities and patient factors.
Discontinue amikacin and maintain piperacillin-tazobactam monotherapy.
Dual antipseudomonal therapy is not indicated once in vitro susceptibility to a beta-lactam is confirmed. Stopping the aminoglycoside is especially critical given the patient's acute kidney injury.

Key Concept

Definitive management of Ventilator-Associated Pneumonia (VAP) requires de-escalating from broad-spectrum empiric therapy to targeted monotherapy once pathogen susceptibilities are identified.
Question 2452Question →

Match each inpatient clinical scenario with the most appropriate targeted pharmacologic intervention based on current clinical guidelines.

Click a left item, then click its matching right item

Items

A 68-year-old man develops ventilator-associated pneumonia on hospital day 8. Sputum cultures are pending, but he has a known history of colonization with extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae.
A 54-year-old woman with acute myeloid leukemia has profound neutropenia and persistent fever despite broad-spectrum antibacterial therapy for 5 days. Chest computed tomography reveals a pulmonary macronodule surrounded by a ground-glass perimeter.
A 75-year-old woman presents with severe lower abdominal pain, a leukocyte count of 32,000/mm³, and copious watery diarrhea two weeks after completing a course of levofloxacin for an upper respiratory infection.
A 42-year-old man is admitted with acute-onset high fever and a new holosystolic murmur. Blood cultures rapidly grow methicillin-resistant Staphylococcus aureus (MRSA) with a vancomycin minimum inhibitory concentration (MIC) of 4.0 mcg/mL.

Matches

Show answer & explanation

Answer

ESBL pneumonia is treated with meropenem; invasive pulmonary aspergillosis presenting with a halo sign requires voriconazole; severe C. difficile infection mandates oral fidaxomicin; and high-MIC MRSA endocarditis requires switching to daptomycin.
Each clinical scenario requires a critical deviation from standard empiric broad-spectrum therapy based on diagnostic clues: carbapenems for confirmed ESBL exposure, voriconazole for the characteristic fungal 'halo sign', fidaxomicin for severe toxin-mediated colitis, and daptomycin for highly resistant MRSA bacteremia.

Step-by-Step Solution

1
Analyze each patient's clinical presentation, laboratory data, and radiographic imaging to definitively diagnose the specific pathogen or pathological complication.
Identified: ESBL Klebsiella pneumonia, invasive pulmonary aspergillosis, severe C. difficile colitis, and high-MIC MRSA endocarditis.
Accurate identification of the underlying pathology and specific resistance mechanism is mandatory before selecting definitive targeted therapy.
2
Determine the optimal targeted therapeutic agent based on antimicrobial stewardship principles, site of infection, and resistance patterns.
Matched the ESBL pathogen to carbapenems, aspergillosis to voriconazole, severe C. difficile to fidaxomicin, and high-MIC MRSA to daptomycin.
Prescribing inappropriate antimicrobial therapies leads to treatment failure, compounding toxicity, and the promotion of further multidrug resistance.

Key Concept

Targeted antimicrobial therapy for severe, resistant, and opportunistic nosocomial infections
Question 2453Question →

Evaluate the following neonatal clinical presentations characterized by gastrointestinal obstruction or feeding intolerance. Match each specific presentation to its precise underlying embryologic or pathophysiologic etiology.

Click a left item, then click its matching right item

Items

A 1-day-old neonate with marked hypotonia and upslanting palpebral fissures begins vomiting dark green material shortly after the first feeding. The abdomen is scaphoid. Upright radiography reveals two prominent upper abdominal air-fluid levels with a complete absence of distal intestinal gas.
A 2-day-old neonate whose mother had erratic prenatal care and a history of illicit stimulant use presents with bilious emesis and significant abdominal distension. Radiography reveals multiple dilated loops of bowel, several air-fluid levels, and a 'triple bubble' appearance.
A full-term male neonate fails to pass meconium by 48 hours of life. He develops severe feeding intolerance and a tensely distended abdomen. Contrast enema demonstrates a narrow-caliber rectum with a reversed rectosigmoid ratio and a distinct transition zone.
A 2-day-old neonate is evaluated for bilious emesis and failure to pass meconium. Radiography shows distended small bowel loops without discernible air-fluid levels and a frothy, granular density localized to the right lower quadrant.

Matches

Show answer & explanation

Answer

The presentations map to the following pathophysiologies: Vignette 1 is duodenal atresia (failure of recanalization). Vignette 2 is jejunoileal atresia (intrauterine vascular compromise). Vignette 3 is Hirschsprung disease (arrested neural crest cell migration). Vignette 4 is meconium ileus (ATP-binding cassette transporter mutation).
Each neonate presents with a distinct form of gastrointestinal obstruction. The 'double bubble' in a Down syndrome infant represents duodenal atresia (failure of recanalization). The 'triple bubble' with maternal cocaine use represents jejunal atresia (mesenteric vascular accident). The transition zone on contrast enema represents Hirschsprung disease (failure of neural crest migration). The ground-glass density without air-fluid interfaces represents meconium ileus due to Cystic Fibrosis (mutation in CFTR, an ATP-binding cassette transporter).

Step-by-Step Solution

1
Analyze the first clinical presentation and radiographic findings.
The dysmorphic features (Down syndrome) and 'double bubble' sign on X-ray identify duodenal atresia.
Identifying the specific congenital anomaly is prerequisite to determining its embryologic origin. Duodenal atresia uniquely arises from a failure of the bowel lumen to recanalize.
2
Evaluate the second presentation involving maternal stimulant use.
Maternal cocaine use and multiple air-fluid levels/triple bubble sign identify jejunoileal atresia.
Cocaine causes severe vasoconstriction. In the fetus, this leads to mesenteric vascular accidents, which cause ischemic necrosis and subsequent atresia of the jejunum or ileum.
3
Examine the third presentation involving contrast enema findings.
Delayed meconium passage with a transition zone and reversed rectosigmoid ratio diagnoses Hirschsprung disease.
The aganglionic segment remains tonically contracted, causing a functional obstruction. This is due to the failure of neural crest cells to migrate completely to the distal hindgut.
4
Assess the final presentation involving a 'granular density' on X-ray.
The ground-glass appearance (Neuhauser sign) without air-fluid levels indicates meconium ileus, a complication of Cystic Fibrosis.
Thickened meconium prevents the formation of clear air-fluid interfaces. Cystic Fibrosis is caused by defective chloride transport via the CFTR protein (an ATP-binding cassette transporter).

Key Concept

Embryologic and pathophysiologic mechanisms of neonatal gastrointestinal obstructions.
Estimated Time:2m 30s
Question 2454Question →

In the management of systemic autoimmune and inflammatory diseases, disease-modifying antirheumatic drugs (DMARDs) and biologic therapies are mainstays of treatment. However, their use is associated with unique adverse effects that require specific screening and monitoring strategies. Match each medication below with its most characteristic adverse effect profile or required screening parameter.

Click a left item, then click its matching right item

Items

Hydroxychloroquine
Methotrexate
Cyclophosphamide
Adalimumab

Matches

Show answer & explanation

Answer

Hydroxychloroquine matches with retinopathy; Methotrexate matches with hepatotoxicity, stomatitis, and macrocytic anemia; Cyclophosphamide matches with hemorrhagic cystitis; Adalimumab matches with reactivation of latent tuberculosis.
The correct pairings align each rheumatologic medication with its well-established mechanism of toxicity and corresponding monitoring requirement. Hydroxychloroquine accumulates in the retina, causing maculopathy. Methotrexate depletes folate, leading to mucosal and hepatic toxicity. Cyclophosphamide's metabolite acrolein damages the bladder mucosa. Adalimumab inhibits TNF-alpha, which is essential for maintaining granulomas, thus risking the reactivation of latent tuberculosis.

Step-by-Step Solution

1
Identify the primary toxicity profile of Hydroxychloroquine.
Matches with retinopathy requiring regular ophthalmologic screening.
The drug binds to melanin in the retinal pigment epithelium, causing cumulative and potentially irreversible damage.
2
Identify the primary toxicity profile of Methotrexate.
Matches with hepatotoxicity, stomatitis, and macrocytic anemia.
It is a folate antimetabolite; its adverse effects are often mitigated by concurrent folic acid supplementation.
3
Identify the primary toxicity profile of Cyclophosphamide.
Matches with hemorrhagic cystitis and increased risk of bladder carcinoma.
The toxic metabolite acrolein concentrates in the urinary bladder. Mesna and adequate hydration are used for prophylaxis.
4
Identify the primary toxicity profile of Adalimumab.
Matches with reactivation of latent tuberculosis or fungal infections.
As a TNF-alpha inhibitor, it disrupts granuloma integrity, making pre-treatment screening for latent tuberculosis (e.g., interferon-gamma release assay) essential.

Key Concept

Pharmacologic adverse effects and monitoring requirements of DMARDs and biologic agents in rheumatologic diseases.
Question 2455Question →

A 35-year-old woman is evaluated in the clinic for progressively worsening pain and color changes in her fingers. She has a known history of diffuse cutaneous systemic sclerosis. She describes her fingers turning white, then blue, and finally red upon exposure to cold. These episodes are now occurring even in mildly cool environments and are severely impacting her daily activities. Physical examination reveals thickened skin over her hands and forearms, as well as tiny, pitted scars on the distal fingertips. She asks about the therapeutic options available for her condition as it progresses.

Arrange the following interventions in the standard stepwise order of therapeutic escalation for the management of Raynaud phenomenon, from the initial approach to the final option for medically refractory, critical ischemia.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The standard step-wise escalation for Raynaud phenomenon begins with nonpharmacologic measures, followed by dihydropyridine calcium channel blockers, then PDE-5 inhibitors. For severe or threatening ischemia, intravenous prostacyclin analogs are utilized, with digital sympathectomy reserved as a last resort.
The correct sequence reflects the escalating severity of Raynaud phenomenon and the risk-benefit ratio of available therapies. Initial management universally requires nonpharmacologic measures (e.g., ambient warming, avoiding triggers). When symptoms persist, dihydropyridine calcium channel blockers (CCBs) are the established first-line pharmacotherapy due to their strong efficacy and safety profile. If CCBs are insufficient, phosphodiesterase-5 (PDE-5) inhibitors are added as second-line oral therapy. For patients who develop severe, critical digital ischemia or active ulceration despite oral therapies, hospitalization for intravenous prostacyclin analogs (e.g., epoprostenol) is indicated. Finally, if critical ischemia is refractory to maximal medical management, a localized surgical digital sympathectomy is performed as a last resort to prevent digital amputation.

Step-by-Step Solution

1
Identify the primary clinical problem requiring management.
The patient has severe secondary Raynaud phenomenon due to systemic sclerosis.
Recognizing the underlying condition and severity establishes the specific treatment pathway.
2
Determine the universal first-line intervention.
Nonpharmacologic lifestyle modifications.
Avoiding cold triggers and vasoconstrictors (like nicotine) is foundational and must be optimized for all patients.
3
Identify the first-line pharmacologic therapy.
Dihydropyridine calcium channel blockers.
Oral vasodilators like nifedipine are the established standard of care for initial medical therapy.
4
Identify the appropriate second-line escalation for refractory symptoms.
PDE-5 inhibitors.
Agents like sildenafil provide additional, complementary vasodilation when monotherapy fails.
5
Determine the approach for critical, limb-threatening ischemia.
Intravenous prostacyclin analogs, followed by digital sympathectomy if medical therapy fails.
These high-risk interventions are reserved specifically for impending tissue loss or active digital ulcers.

Key Concept

Stepwise escalation of therapy for secondary Raynaud phenomenon in systemic sclerosis.
Question 2456Question →

During a routine evaluation in the newborn nursery, a physician examines a 48-hour-old female infant due to a newly developed skin eruption. The infant was born at 39 weeks of gestation via an uncomplicated vaginal delivery to a healthy mother who received standard prenatal care. Vital signs are within normal limits for age, and the infant is feeding vigorously at the breast. Physical examination reveals multiple erythematous macules, some containing central 1- to 2-millimeter yellowish pustules, scattered across the chest, abdomen, and bilateral thighs. The palms and soles are completely spared. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Routine neonatal care with no specific intervention

Answer

Routine neonatal care with no specific intervention
The correct approach is routine neonatal care with no specific intervention. This patient's presentation of scattered erythematous macules with central pustules, appearing at 48 hours of life and sparing the palms and soles, is the classic description of erythema toxicum neonatorum (ETN). ETN is a very common, benign, and self-limited idiopathic condition seen in full-term neonates. Because the infant is well-appearing, afebrile, and feeding normally, no diagnostic testing or pharmacologic treatment is indicated. The rash typically resolves spontaneously within a week.

Step-by-Step Solution

1
Analyze the clinical presentation and physical examination findings.
A healthy, afebrile 48-hour-old infant presents with an erythematous rash containing central pustules that spares the palms and soles.
Identifying the timing, morphology, and distribution of the rash is essential for distinguishing benign neonatal skin conditions from severe infectious etiologies.
2
Determine the most likely diagnosis.
The clinical picture is classic for erythema toxicum neonatorum (ETN).
ETN typically appears between 24 and 72 hours of life as erythematous macules with central papules or pustules, characteristically sparing the palms and soles.
3
Select the appropriate management strategy based on the diagnosis.
Reassurance and routine care are indicated.
ETN is a benign, asymptomatic, and self-resolving condition that requires no pharmacologic intervention or isolation.

Key Concept

Erythema toxicum neonatorum is a common, benign, self-limited rash in healthy newborns that presents as erythematous macules with central pustules (sparing palms and soles) and requires only parental reassurance and routine care.
Question 2457Question →

A 32-year-old woman brings her 8-week-old daughter to the outpatient clinic for a scheduled preventive care encounter. The mother has a history of severe ulcerative colitis, which was managed with continuous intravenous infliximab therapy throughout her pregnancy; her most recent infusion occurred at 38 weeks gestation. The infant has been exclusively breastfed and demonstrates appropriate weight gain. Developmental assessment reveals that the infant coos, exhibits a social smile, and successfully tracks objects past the midline. Vital signs are within normal limits. Skin examination reveals a scattered eruption of small, firm, yellow-white papules surrounded by an erythematous halo over the trunk. The remainder of the physical examination is unremarkable. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administer the first doses of DTaP, Hib, IPV, and PCV vaccines, and omit the rotavirus vaccine

Answer

Administer the first doses of DTaP, Hib, IPV, and PCV vaccines, and omit the rotavirus vaccine
The correct management is to administer the scheduled inactivated vaccines (DTaP, Hib, IPV, and PCV) but omit the live-attenuated rotavirus vaccine. Infliximab is a monoclonal IgG1 antibody that actively crosses the placenta, especially during the third trimester. Infants born to mothers receiving this therapy are considered immunocompromised for the first 6 months of life due to persistent circulating levels of the biologic drug. Consequently, live-attenuated vaccines (e.g., rotavirus, BCG) are contraindicated during this window due to the risk of uncontrolled vaccine-strain infection. Inactivated vaccines are safe and must not be delayed. The infant's rash is erythema toxicum neonatorum, a benign condition, and her milestones are entirely normal for her age.

Step-by-Step Solution

1
Assess the impact of maternal infliximab therapy on the infant's immune status.
Infliximab is an IgG1 monoclonal antibody that crosses the placenta, particularly during the third trimester, leaving the infant transiently immunocompromised for up to 6 months of age.
Understanding placental transfer of biologics is required to determine vaccine safety.
2
Determine the appropriate vaccine schedule for a 2-month-old infant with transient immunosuppression.
Inactivated vaccines (DTaP, Hib, IPV, PCV) are safe and should be given on schedule. The live-attenuated rotavirus vaccine is contraindicated and must be omitted.
Live-attenuated vaccines carry a risk of disseminated, potentially fatal infection in immunocompromised hosts.
3
Evaluate the infant's dermatologic findings and developmental milestones.
The yellow-white papules on an erythematous base indicate erythema toxicum neonatorum, which is benign. The milestones (cooing, social smile, tracking past midline) are normal for 8 weeks.
Rules out the need to delay vaccines for acute illness or refer for developmental delay.

Key Concept

Immunization management in infants exposed to transplacental biologic immunosuppressants
Question 2458Question →

A 65-year-old man is hospitalized for community-acquired pneumonia. Upon admission, he was empirically started on intravenous ceftriaxone and azithromycin. Two days later, his clinical condition has significantly improved. He is now afebrile, his oxygen saturation is 96% on room air, and his cough has decreased. He is eating well and tolerating oral intake. Sputum culture results return positive for Streptococcus pneumoniae. Susceptibility testing shows the organism is highly sensitive to penicillin, amoxicillin, ceftriaxone, and levofloxacin. Which of the following is the most appropriate next step in pharmacotherapy?

Show answer & explanation

Answer: Transition to oral amoxicillin

Answer

Transition to oral amoxicillin
The patient has community-acquired pneumonia that has clinically improved, and he is now able to tolerate oral intake. This marks the appropriate time to transition from intravenous to oral antibiotics. Furthermore, culture results show Streptococcus pneumoniae that is highly sensitive to amoxicillin. According to principles of antibiotic stewardship, therapy should be de-escalated to the narrowest spectrum agent that is effective. Oral amoxicillin perfectly fits these criteria, minimizing the risk of adverse effects and antimicrobial resistance.

Step-by-Step Solution

1
Evaluate the patient's clinical trajectory.
The patient is afebrile, oxygenating well on room air, and tolerating oral intake, indicating readiness to switch from intravenous to oral therapy.
Clinical stability dictates whether a patient can be safely de-escalated to oral antibiotics.
2
Analyze the culture and susceptibility data.
Sputum culture confirms Streptococcus pneumoniae that is sensitive to penicillin and amoxicillin.
Culture data allows for de-escalation from empiric broad-spectrum coverage to targeted narrow-spectrum therapy.
3
Select the most appropriate targeted therapy.
Oral amoxicillin provides the narrowest effective spectrum for this pathogen in an orally bioavailable form.
Antibiotic stewardship principles require using the narrowest spectrum, most effective, and least toxic agent available.

Key Concept

Antibiotic stewardship and de-escalation in community-acquired pneumonia
Question 2459Question →

A 54-year-old woman is evaluated on the general medical ward for new-onset chills and a temperature of 38.8°C (101.8°F). She recently completed her second cycle of systemic chemotherapy for invasive ductal carcinoma. Laboratory studies demonstrate a white blood cell count of 900/mm³ and an absolute neutrophil count of 250/mm³. Her blood pressure is 110/70 mm Hg, pulse is 105/min, and respiratory rate is 18/min. Physical examination reveals an indwelling central venous port in the right upper chest with no overlying erythema, fluctuance, or tenderness. The remainder of the examination is unremarkable.

Arrange the following steps in the most appropriate chronological order for the acute diagnostic and therapeutic management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first obtain peripheral and central blood cultures, followed immediately by empiric antipseudomonal beta-lactam antibiotics. The patient is then monitored for 48 to 72 hours on this initial regimen, and an empiric antifungal agent is added only if fever persists beyond 4 to 7 days.
The management of neutropenic fever relies on a protocolized sequence to balance the risk of overwhelming sepsis against antimicrobial stewardship principles. Because these patients lack a robust inflammatory response, infections can progress rapidly. The immediate first step is obtaining blood cultures (including from any central lines) to maximize pathogen recovery. Immediately after cultures are drawn, broad-spectrum empiric antibiotics with antipseudomonal coverage (e.g., cefepime, meropenem) must be initiated within 60 minutes. The median time to defervescence is 2 to 5 days; therefore, the initial regimen should be continued without alteration for 48 to 72 hours if the patient remains hemodynamically stable. If unexplained fever persists beyond 4 to 7 days despite appropriate antibacterial coverage, the risk of an invasive fungal infection increases substantially, warranting the addition of an empiric antifungal agent.

Step-by-Step Solution

1
Draw peripheral and central venous blood cultures.
Pathogens present in the bloodstream are captured before exposure to antibiotics.
Maximizes the diagnostic yield, allowing for subsequent targeted antimicrobial de-escalation.
2
Administer broad-spectrum antipseudomonal antibiotics.
Immediate coverage against life-threatening bacterial pathogens (e.g., Pseudomonas aeruginosa) is provided.
Neutropenic patients lack the immune cells required to localize infections, making rapid empiric coverage essential.
3
Monitor the patient for 48 to 72 hours without altering the antibiotic regimen.
Adequate time is given for the initial antibiotics to take effect.
The median time to defervescence in neutropenic fever is 2 to 5 days; premature escalation in a stable patient is unwarranted.
4
Initiate empiric antifungal therapy if unexplained fever persists after 4 to 7 days.
Occult invasive fungal infections are treated.
Prolonged neutropenia and broad-spectrum antibiotic use significantly increase the risk for fungal infections (e.g., Candida, Aspergillus).

Key Concept

Algorithmic management of febrile neutropenia
Estimated Time:1m 30s
Question 2460Question →

A 72-year-old male with a history of metastatic prostate cancer is admitted directly to the inpatient medical ward from his oncologist's clinic due to rapidly progressive lower extremity weakness. He reports a two-week history of worsening thoracic back pain that frequently awakens him from sleep. Over the last 24 hours, he has become entirely unable to stand or walk. He also mentions an inability to urinate since early this morning. Vital signs are within normal limits. Neurologic examination shows symmetric 2/5 motor strength in the lower extremities, diminished pinprick sensation below the T10 dermatome, and bilateral Babinski signs. A distended, palpable bladder is noted on abdominal examination. Complete blood count and basic metabolic panel, including serum calcium, are unremarkable.

Which of the following is the most appropriate initial step in the management of this patient?

Show answer & explanation

Answer: Administration of intravenous dexamethasone

Answer

The most appropriate initial step is the administration of intravenous dexamethasone.
The patient's presentation of progressive back pain, bilateral lower extremity weakness, sensory level deficits, upper motor neuron signs (Babinski), and autonomic dysfunction (urinary retention) in the setting of metastatic prostate cancer is highly suspicious for neoplastic epidural spinal cord compression (ESCC). ESCC is a critical neurologic emergency. The immediate priority is to reduce vasogenic edema and relieve pressure on the spinal cord to prevent irreversible ischemia and permanent paralysis. Therefore, the administration of high-dose intravenous corticosteroids (such as dexamethasone) is the most appropriate initial step. It must be given as soon as the diagnosis is suspected clinically, prior to any confirmatory imaging.

Step-by-Step Solution

1
Evaluate the patient's clinical signs and oncologic history.
Identify severe back pain, acute motor weakness, a sensory level deficit, and autonomic dysfunction (urinary retention) in a patient with known metastatic prostate cancer.
To recognize the classic presentation of neoplastic epidural spinal cord compression (ESCC), a major oncologic emergency.
2
Formulate a management priority based on the presence of acute neurologic deficits.
Determine that the immediate priority is to relieve pressure on the spinal cord to prevent permanent ischemia and irreversible paralysis.
In ESCC, 'time is spine'; any delay in relieving vasogenic edema can result in permanent loss of neurologic function.
3
Select the most appropriate initial intervention.
Choose the administration of high-dose intravenous corticosteroids (e.g., dexamethasone).
Corticosteroids act rapidly to decrease spinal cord edema and must be given immediately upon clinical suspicion, even prior to obtaining confirmatory imaging.

Key Concept

Management sequence for neoplastic epidural spinal cord compression
PreviousPage 123 / 414Next
All practice questions — USMLE Step 2 CK | Examkin